Otonomy Reports First Quarter 2016 Financial Results and Provides Corporate Update

Back to Jobs

SAN DIEGO , May 09, 2016 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today reported financial results for the quarter ended March 31, 2016 and

Apply Now